Literature DB >> 3792780

Mycobacteria and inflammatory bowel disease. Results of culture.

D Y Graham, D C Markesich, H H Yoshimura.   

Abstract

We have been able to isolate mycobacteria from intestinal specimens obtained by surgical resection or endoscopic biopsy from patients with Crohn's disease, ulcerative colitis, and noninflammatory bowel diseases. Nineteen slow-growing (Runyon groups I and III) and 17 rapid-growing (Runyon group IV) mycobacterial isolates were obtained. Slow-growing mycobacteria were recovered from approximately one-third of intestinal biopsy specimens from Crohn's disease, one-quarter of ulcerative colitis biopsies, and 40% of biopsies from noninflammatory bowel disease patients. Isolates were most commonly members of the Mycobacterium avium-complex. One isolate (from an ulcerative colitis patient) was biochemically similar to the Mycobacterium strain previously associated with Crohn's disease, and one from a Crohn's disease patient was Mycobacterium kansasii. The rapid-growing organisms were members of the Mycobacterium fortuitum-complex. In addition to conventional mycobacteria, spheroplasts (cell wall-defective forms) were isolated from 12 patients with Crohn's disease (most often from surgically resected colon) and 3 patients with ulcerative colitis; none were isolated from non-inflammatory bowel disease patients. We have been unable to identify a consistent relationship between the presence, or the species, of Mycobacterium and Crohn's disease. Our results do not support the proposed role of a specific mycobacterium in the pathogenesis of Crohn's disease. The cause of Crohn's disease remains unclear.

Entities:  

Mesh:

Year:  1987        PMID: 3792780     DOI: 10.1016/0016-5085(87)90139-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

1.  Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.

Authors:  T S Halstensen; T E Mollnes; P Garred; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives.

Authors:  L G Wayne; D Hollander; B Anderson; H A Sramek; C M Vadheim; J I Rotter
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

Review 3.  Mycobacterial diseases of the gut: some impact from molecular biology.

Authors:  J D Sanderson; J Hermon-Taylor
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

Review 4.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

5.  Observations on the Kveim reaction using an animal model of granulomatous bowel disease.

Authors:  I C Mitchell; J L Turk
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

6.  In the search of a cause of Crohn's disease.

Authors:  Govind K Makharia; Urvashi B Singh
Journal:  Indian J Gastroenterol       Date:  2009 Sep-Oct

Review 7.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 8.  The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis.

Authors:  T W Rademacher; R B Parekh; R A Dwek; D Isenberg; G Rook; J S Axford; I Roitt
Journal:  Springer Semin Immunopathol       Date:  1988

Review 9.  Mycobacterium avium subspecies paratuberculosis causes Crohn's disease in some inflammatory bowel disease patients.

Authors:  Saleh A Naser; Sudesh R Sagramsingh; Abed S Naser; Saisathya Thanigachalam
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

10.  Preliminary report on isolation of mycobacteria from patients with Crohn's disease.

Authors:  G Gitnick; J Collins; B Beaman; D Brooks; M Arthur; T Imaeda; M Palieschesky
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.